EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?

Benjamin Fongenie, Nathaniel Scott, Nicolas Chouin, Ana M. Denis-Bacelar, Daniel J. Stevens

EANM Innovation · 2026-06 · 3 · 100129

DOI: 10.1016/j.eanmi.2026.100129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EANM Innovation, 2026-06. Verfasst von Benjamin Fongenie und 4 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fongenie, B., Scott, N., Chouin, N., Denis-Bacelar, A. M., & Stevens, D. J. (2026). Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?. EANM Innovation, 3, 100129. https://doi.org/10.1016/j.eanmi.2026.100129

Vancouver

Fongenie B, Scott N, Chouin N, Denis-Bacelar AM, Stevens DJ. Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?. EANM Innovation. 2026;3:100129. doi:10.1016/j.eanmi.2026.100129

BibTeX
@article{Fongenie2026,
  author = {Fongenie, Benjamin and Scott, Nathaniel and Chouin, Nicolas and Denis-Bacelar, Ana M. and Stevens, Daniel J.},
  title = {Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?},
  journal = {EANM Innovation},
  year = {2026},
  volume = {3},
  pages = {100129},
  doi = {10.1016/j.eanmi.2026.100129}
}
Kostenlos starten →